Telesis Bio IncNASDAQ:TBIONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.3213
- TODAY'S CHANGE (%)-0.0022 (-0.6801%)
- Bid / Lots0.3100/ 6
- Ask / Lots0.3400/ 2
- Open / Previous Close0.3010 / 0.3235
- Day Range
- 52 Week Range
- Volume127,758
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TBIO |
|---|---|---|
| 09:32 ET | 1300 | 0.301 |
| 09:34 ET | 3000 | 0.3101 |
| 09:36 ET | 1270 | 0.31 |
| 09:39 ET | 313 | 0.3101 |
| 09:45 ET | 4212 | 0.32 |
| 10:08 ET | 6000 | 0.32 |
| 10:17 ET | 100 | 0.327 |
| 10:21 ET | 3000 | 0.327 |
| 10:26 ET | 200 | 0.3227 |
| 10:28 ET | 25594 | 0.3275 |
| 10:35 ET | 214 | 0.33999 |
| 10:37 ET | 500 | 0.3301 |
| 10:44 ET | 15156 | 0.34 |
| 10:46 ET | 2198 | 0.34 |
| 10:53 ET | 3393 | 0.3402 |
| 11:06 ET | 1980 | 0.3397 |
| 11:11 ET | 180 | 0.3401 |
| 11:20 ET | 10690 | 0.3301 |
| 11:22 ET | 100 | 0.33 |
| 11:42 ET | 8200 | 0.33 |
| 11:44 ET | 4300 | 0.33 |
| 11:45 ET | 4100 | 0.3301 |
| 11:49 ET | 11598 | 0.3102 |
| 11:56 ET | 300 | 0.3499 |
| 12:14 ET | 400 | 0.3101 |
| 12:32 ET | 600 | 0.3256 |
| 12:34 ET | 200 | 0.325 |
| 12:38 ET | 2300 | 0.3145 |
| 12:41 ET | 100 | 0.33225 |
| 01:17 ET | 100 | 0.31501 |
| 01:19 ET | 100 | 0.326 |
| 01:30 ET | 100 | 0.3492 |
| 01:46 ET | 100 | 0.3321 |
| 01:50 ET | 100 | 0.3321 |
| 01:51 ET | 500 | 0.3487 |
| 01:53 ET | 400 | 0.3389 |
| 02:29 ET | 300 | 0.3442 |
| 02:42 ET | 100 | 0.3474 |
| 02:49 ET | 300 | 0.3491 |
| 03:21 ET | 100 | 0.349 |
| 03:27 ET | 317 | 0.3491 |
| 03:45 ET | 110 | 0.3492 |
| 03:54 ET | 100 | 0.349 |
| 03:57 ET | 2700 | 0.3296 |
| 03:59 ET | 648 | 0.3213 |
Apr 18, 2024
Mar 28, 2024
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
4:05PM ET on Thursday Mar 28, 2024 by Dow JonesTelesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
4:05PM ET on Thursday Mar 28, 2024 by Dow Jones*DJ Telesis Bio 4Q Loss/Shr 61c >TBIO, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Telesis Bio Inc | 9.7M | -0.2x | --- |
STRATA Skin Sciences Inc | 18.9M | -1.8x | --- |
Aamaxan Transport Group Inc | 1.6K | 0.0x | --- |
Prosomnus Inc | 3.0M | -0.2x | --- |
Micron Solutions Inc | 4.0M | -1.7x | --- |
Sensus Healthcare Inc | 55.7M | 112.5x | --- |
Company Information
Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The Company provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.
Contact Information
- Headquarters
- 10431 Wateridge Circle, Suite 150SAN DIEGO, CA, United States 92121
- Phone
- 858-228-4115
- Fax
- 302-636-5454
Executives
- Non-Executive Independent Chairman of the Board
- Franklin Witney
- President, Chief Executive Officer, Director
- Eric Esser
- Chief Financial Officer
- William Kullback
- Chief Technology Officer
- Daniel Gibson
- Chief Legal Officer
- Robert Cutler
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.7M |
|---|---|
Revenue (TTM) | $27.5M |
Shares Outstanding | 30.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.64 |
Book Value | $0.98 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 0.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -169.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
